PDB19 ESTIMATING THE COST EFFECTIVENESS IN THE UK OF VILDAGLIPTIN COMPARED TO PIOGLITAZONE AS ADD-ON THERAPY TO METFORMIN USING THE SHEFFIELD TYPE 2 DIABETES MODEL
Abstract
Authors
A Brennan M Gillett A Duenas
A Brennan M Gillett A Duenas
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now